REGN Regeneron Pharmaceuticals · $676.69 Neutral — no clear edge中性 — 无明显优势 Terminal终端 ↗

All coverage所有股票 · Health Care

Regeneron Pharmaceuticals · Health Care

REGN

$676.69
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.RegeneronPharmaceuticals,Inc.是一家美国生物技术公司，总部位于纽约州威斯特彻斯特县。
Mixed profile混合特征
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 607.93.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 607.93 下方。
Open in Terminal打开终端 ↗ All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$676.69
16.5% below 52-week high低于52周高点 16.5%
Beta贝塔
0.40
Moves about 0.4x the market波动幅度约为市场的 0.4 倍
RSI (14)RSI（14）
62
Elevated偏高
Next Earnings下次财报
2026-08-07 (19d)
Volatility Rank波动率分位
20th pctile
hist. vol. percentile历史波动率分位数

Performance价格表现

Period周期 REGN S&P 500vs Index对比指数
1 Week近1周 +1.8% -1.5% Beat the index by 3.3 points跑赢指数 3.3 个百分点
1 Month近1月 +11.3% +0.6% Beat the index by 10.7 points跑赢指数 10.7 个百分点
3 Months近3月 -9.7% +4.7% Lagged the index by 14.4 points落后指数 14.4 个百分点
6 Months近6月 -7.4% +7.8% Lagged the index by 15.2 points落后指数 15.2 个百分点
Year to date年初至今 -12.6% +9.1% Lagged the index by 21.7 points落后指数 21.7 个百分点
1 Year近1年 +23.7% +19.4% Beat the index by 4.3 points跑赢指数 4.3 个百分点

Technicals技术面

RSI (14)RSI（14） 62 Elevated偏高
vs 50-day相对50日均线 +4.8% vs 50-day avg
vs 200-day相对200日均线 -3.7% vs 200-day avg
Volatility rank波动率分位 20th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$655.85
Don't chase above不追高于
$676.70
Stop止损
$607.90
Bounce — turn not confirmed; wait反弹 — 转向未确认，先观望

Earnings财务业绩

19
days until next report天后公布财报
2026-08-07

Estimates being cut预期下调

Post-earnings drift: -16.7% (20d)财报后漂移：-16.7%（20日）

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Financials财务数据

Revenue营业收入
$8.5B
2020
$16.1B
2021
$12.2B
2022
$13.1B
2023
$14.2B
2024
$14.3B
2025
5yr CAGR5年复合增速: 11.0%
Earnings Per Share每股收益
$30.52
2020
$71.97
2021
$38.22
2022
$34.77
2023
$38.34
2024
$41.48
2025
5yr CAGR5年复合增速: 6.3%
Free Cash Flow自由现金流
$2.0B
2020
$6.5B
2021
$4.4B
2022
$3.9B
2023
$3.7B
2024
$4.1B
2025
Margins利润率
Operating margin营业利润率
24.9%
Net margin净利率
31.4%
FCF margin自由现金流利润率
34.7%
14.4%Return on Equity股本回报率
11.1%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.27
Current ratio流动比率4.13
Capital Allocation资本配置
Buybacks (TTM)回购（TTM）$3.4B
Stock-based comp股权薪酬$993.7M
Piotroski皮奥特罗斯基 4/7 Clean稳健

Snapshot Gauges综合指标

Beta市场敏感度
0.40×
0.21×3×
Moves about 0.4× the market波动幅度约为市场的 0.4 倍
Financial Health财务健康
4/7
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息

Why Is It Moving为何波动

News新闻 2 recent stories — mixed2 篇最新报道，多空参半
Sector / Theme行业/主题 Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 NEARING A HIGH → BOTTOMING接近高点 → 筑底中

Options Positioning期权持仓

Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡

Expected daily move预期日波动
±2.24%
Expected weekly move预期周波动
±5.02%
Call wall看涨密集区
$740
Put wall看跌密集区
$600
Gamma flip伽玛翻转
$634
25d risk reversal25d风险逆转
-2.2%
Skew: 偏斜：balanced

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$9.2M net (0 buyers, 5 sellers)-$9.2M 净值（0 买家，5 卖家）
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
Scion Asset Mgmt (Burry) A exitexit 0.0% 2025-09-30

Signal History信号历史

BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum curling up; investor cycle overdue; last cycle left-translated (topped early)). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up. Last cycle was left-translated (topped early) — a bearish structural tell高风险 · 仅限灵活操作。正在形成日线筑底形态（摆动低点已现、动量转向上行）——但更高周期尚未确认：大局仍偏空（周线动量开始上翘；投资者周期已逾期；上一周期左移（见顶偏早））。这是「未确认转向」，并非已确认的买入。周线确认滞后于价格，因此同样的读数既涵盖最终失败的反弹，也涵盖真正新周期的第一段——实时无法判定属于哪一种，故应将其视为风险/仓位信号，而非方向判断。实测：周线未确认的筑底形态约 49% 守住低点，周线转向后升至约 68%。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
COUNTERTREND BOUNCE UNCONFIRMED TURN
Jul 9, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jun 22, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 15, 2026
DOWNTREND → NEARING A LOW下跌趋势 → 接近低点
GET READY准备
Jun 12, 2026
Death cross on REGNREGN 死叉
The 50-day average crossed below the 200-day — a slow, widely-watched bearish trend signal. $612.14.50日均线下穿200日均线 — 一个滞后但广受关注的看空趋势信号。$612.14。
Jun 8, 2026
UPTREND → DOWNTREND上涨趋势 → 下跌趋势
AVOID回避
Jun 8, 2026
REGN broke down vs the marketREGN 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $611.34.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$611.34。

Showing last 15 of显示最近15条，共 88 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: 0.30
Quality质量
+0.5
Investment资本投入
+0.1
Low volatility低波动
+0.4
Low market beta低市场敏感度
+0.6
Earnings quality盈利质量
-0.6
Short interest空头兴趣
+0.6

Company Profile公司档案

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.RegeneronPharmaceuticals,Inc.是一家美国生物技术公司，总部位于纽约州威斯特彻斯特县。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Capital intensity rising

Recent News最新动态

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm GlobeNewswire Inc. 2026-07-19
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes GlobeNewswire Inc. 2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。
Open Analyzer打开分析器 Browse All Stocks浏览所有股票